Genotype-phenotype correlation in murine Apc mutation: Differences in enterocyte migration and response to sulindac

Cancer Research

Volumn 59, Issue 2, 1999, Pages 353-359

  Mahmoud, Najjia N ^a   Bilinski, Robyn T ^a   Churchill, Matthew R ^a   Edelmann, Winfried ^c   Kucherlapati, Raju ^c   Bertagnolli, Monica M ^a,b  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b STRANG CANCER PREVENTION CENTER   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; SULINDAC;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; GENE EXPRESSION; GENE MUTATION; GENOTYPE; INTESTINE CELL; INTESTINE TUMOR; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADENOMATOUS POLYPOSIS COLI; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BETA CATENIN; CELL MOVEMENT; CYTOSKELETAL PROTEINS; FEMALE; GENES, APC; GENOTYPE; INTESTINAL MUCOSA; INTESTINES; MICE; MUTATION; PHENOTYPE; PRECANCEROUS CONDITIONS; SULINDAC; TRANS-ACTIVATORS;

EID: 0033556002     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Oshima, M., Oshima, H., Kitagawa, K., Kobayashi, M., Itakura, C., and Taketo, M. Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc. Natl. Acad. Sci. USA, 92: 4482-4486, 1995.
2. Jen, J., Powell, S., Papadopoulos, N., Smith, K. J., Hamilton, S. R., Vogelstein, B., and Kinzler, K. W. Molecular determinants of dysplasia in colorectal lesions. Cancer Res., 54: 5523-5526, 1994.
3. Lynch, H. T., Smyrk, T., McGinn, T., Lanspa, S., Cavalieri, J., Lynch, J., Slominski-Castor, S., Cayouette, M. C., Priluck, I., and Luce, M. C. Attenuated familial adenomatous polyposis (AFAP). Cancer (Phila.), 76: 2427-2433, 1995.
4. Spirio, L., Olschwang, S., Groden, J., Robertson, M., Samowitz, W., Joslyn, G., Gelbert, L., Thliveris, A., Carlson, M., Otterud, B., Lynch, H., Watson, P., Hughes, J. P. Thomas, G., Leppert, M., and White, R. Alleles of the APC gene: an attenuated form of familial polyposis. Cell, 75: 951-957, 1993.
5. Wu, J. S., Paul, P., McGannon, E. A., and Church, J. M. APC genotype, polyp number, and surgical options in familial adenomatous polyposis. Ann. Surg., 227: 57-62, 1998.
6. Nagase, H., Miyoshi, Y., Horii, A., Aoki, T., Ogawa, M., Utsunomiya, J., Baba, S., Sasazuki, T., and Nakamura, Y. Correlation between the location of germ-line mutations in the APC gene and the number of colorectal polyps in familial adenomatous polyposis patients. Cancer Res., 52, 4055-4057, 1992.
7. Smith, K. J., Johnson, K. A., Bryan, T. M., Hill, D. E., Markowitz, S., Willson, J. V. K., Paraskeva, C., Petersen, G. M., Hamilton, S. R., Vogelstein, B., and Kinzler, K. W. The APC gene product in normal and tumor cells. Proc. Natl. Acad. Sci. USA, 90: 2846-2850, 1993.
8. Muraoka, M., Takahashi, H., Amada, Y., Fukayama, M., Maeda, Y., Iwama, T., Mishima, Y., Mori, T., and Koike, M. Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors. Cancer Res., 54: 3011-3020, 1994.
9. Dobbie, Z., Spycher, M., Mary, J. L., Haner, M., Guldenschuh, I., Hurliman, R., Amman, R., Roth, J., Muller, H., and Scott, R. J. Correlation between the development of extracolonic manifestations in FAP patients and mutations beyond codon 1403 in the APC gene. J. Med. Genet., 33: 274-280, 1996.
10. Joslyn, G., Richardson, D. S., White, R., and Alber, T. Dimer formation by an N-coiled coil in the APC protein. Proc. Natl. Acad. Sci. USA, 90: 11109-11113, 1993.
11. Su, L-K., Johnson, K. A., Smith, K. J., Hill, D. E., Vogelstein, B., and Kinzler, K. W. Association between wild type and mutant APC gene products. Cancer Res., 53: 2728-2731, 1993.
12. Su, L-K., Kinzler, K., Vogelstein, B., Preisinger, A. C., Moser, A. R., Luongo, C., Gould, K., and Dove, W. F. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science (Washington DC), 256: 668-670, 1992.
13. Mahmoud, N. N., Boolbol S. K., Bilinski, R. T., Martucci, C. M., Chadburn, A., and Bertagnolli, M. M. Apc gene mutation is associated with a dominant negative effect upon intestinal cell migration. Cancer Res., 57: 5045-5050, 1997.
14. Fodde, R., Edelmann, W., Yang, K., van Leeuwen, C., Carlson, C., Renault, B., Breukel, C., Alt, E., Lipkin, M., Meera Khan, P., and Kucherlapati, R. A target chain termination mutation in the mouse Apc gene results in multiple intestinal tumors. Proc. Natl. Acad. Sci. USA, 91: 8969-8973, 1994.
15. Munemitsu, A., Albert, I., Souza, B., Rubinfeld, B., and Polakis, P. Regulation of intracellular β-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc. Natl. Acad. Sci. USA, 92: 3046-3050, 1995.
16. Näthke, I. S., Adams, C. L., Polakis, P., Sellin, J. H., and Nelson, W. J. The adenomatous polyposis coli tumor suppressor protein localizes to plasma membrane sites involved in active cell migration. J. Cell. Biol., 134: 165-179, 1996.
17. Wong, M. H., Hermiston, M. L., Syder, A. J., and Gordon, J. I. Forced expression of the tumor suppressor adenomatosis polyposis coli protein induces disordered cell migration in the intestinal epithelium. Proc. Natl. Acad. Sci. USA, 93: 9588-9593, 1996.
18. Luongo, C., Moser, A. R., Gledhill, S., and Dove, W. F. Loss of APC+ in intestinal adenomas from Min mice. Cancer Res., 54: 5947-5952, 1994.
19. Boolbol, S. K., Dannenberg, A. J., Chadburn, A., Martucci, C., Guo, X-J., Ramonetti, J. T., Abreu-Goris, M., Newmark, H. L., Lipkin, M. L., DeCosse, J. J., and Bertagnolli, M. M. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res. 56: 2556-2560, 1996.
20. Mahmoud, N. N., Boolbol, S. K., Dannenberg, A. J., Mestre, J. R., Bilinski, R. T., Newmark, H. L., Chadburn, A., and Bertagnolli, M. M. The sulfide metabolize of sulindac prevents tumors and restores enterocyte apoptosis in a murine model of familial adenomatous polyposis. Carcinogenesis (Lond.), 19: 87-91, 1998.
21. Waddell, W. R., and Loughry, R. W. Sulindac for polyposis of the colon. J. Surg. Oncol., 24: 83-87, 1983.
22. Giardiello, F. M., Hamilton, S. R., Krush, A. J., Piantadosi, S., Hylind, L. M., Ce ano, P., Booker, S. V., Robinson, C. R., and Offerhaus, G. J. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med., 328: 1313-1316, 1993.
23. Labayle, D., Fischer, D., Vielh, P., Drouhin, F., Pariente, A., Bories, C., Duhame , O., Trousset, M., and Attali, P. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology, 101: 635-639, 1991.
24. Rubinfeld, B., Albert, I., Porfiri, E., Fiol, C., Munemitsu, S., and Polakis, P. Binding of GSK3β to the APC-β-catenin complex and regulation of complex assembly. Science (Washington DC), 272: 1023-1026, 1996.
25. Takahashi, M., Fukuda, K., Sugimura, T., and Wakabayashi, K. β-Catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors. Cancer Res., 58: 42-46, 1998.
26. Morin, P. J., Sparks, A. B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B. and Kinzler, K. W. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science (Washington DC), 275: 1787-1790, 1997.
27. Miller, J. R., and Moon, R. T. Signal transduction through β-catenin and specification of cell fate during embryogenesis. Genes Dev., 10: 2527-2539, 1996.
28. Kurinek, V., Barker, N., Morin, P. J., van Wichen, D., de Weger, R., Kinzler, K W., Vogelstein, B., and Clevers, H. Constitutive transcriptional activation by a β-catenin-Tcf complex in APC / colon carcinoma. Science (Washington DC), 275: 1784-1787, 1997.
29. Peifer, M. β-Catenin as oncogene: the smoking gun. Science (Washington DC), 275: 1752-1753, 1997.
30. Joslyn, G., Carlson, M., Thliveris, A., Albertsen, H., Gelbert, L., Samowitz, W., Groden, J., Stevens, J., Spirio, L., Robertson, M., Krapcho, K., Sargent, L., Wolff, E., Burt, R., Hughes, J. P., Warrington, J., McPherson, J., Wasmuth, J., Le Pasliet, D., Abderrahim, H., Cohen, D., Leppert, M., and White, R. Identification of deletion mutations and three new genes at the familial polyposis locus. Cell, 66: 601-613, 1991.
31. Groden, J., Thliveris, A., Samowitz, W., Carlson, M., Gelbert, L. Albertsen, H., Joslyn, G., Stevens, J., Spirio, L., Robertson, M., Sargeant, L., Krapcho, K., Wolff, E., Burt, R., Highes, J. P., Warrington, J., McPherson, J., Wasmuth, J., Le Pasliet, D., Adberrahim, H., Cohen, D., Leppert, M., and White, R. Identification and characterization of the familial adenomatous polyposis coli gene. Cell. 66: 589-600, 1991.
32. Kinzler, K. W., Nilbert, M. C., Su, L-K., Vogelstein, B., Bryan, T. M., Levy, D. B., Smith, K. J., Preisinger, A. C., Hedge, P., McKechnie, D., Finniear, R., Markham, A., Groffen, J., Boguski, M. S., Altschul, S. F., Horii, A., Ando, H., Miyoshi, Y., Miki, Y., Nishisho, I., and Nakamura, Y. Identification of FAP locus genes from chromosome 5q21. Science (Washington DC), 253: 661-665, 1991.
33. Peifer, M., Berg, S., Reynolds, A. D. A repeating amino acid motif shared by proteins with diverse cellular roles. Cell, 76: 789-791, 1994.
34. Polakis, P. Mutations in the APC gene and their implications for protein structure and funtion. Curr. Opin. Genet. Dev., 5: 66-71, 1995.
35. Rubinfeld, B., Souza, B., Albert, I., Muller, O., Chamberlain, S., Masiarz, F. R., Munemitsu, S., and Polakis, P. Association of the APC gene product with β-catenin. Science (Washington DC), 262: 1731-1734, 1993.
36. Su, L-K., Vogelstein, B., and Kinzler K. W. Association of the APC tumor suppressor protein with catenins. Science (Washington DC), 262: 1734-1737, 1993.
37. Miyaki, M., Konishi, M., Kikuchi-Yanoshita, R., Enomoto, M., Igari, T., Tanaka, K., Muraoka, M., Takahashi, H., Amada, Y., Fukayama, M., Maeda, Y., Iwama, T., Mishima, Y., Mori, T., and Koike, M. Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors. Cancer Res., 54: 3011-3020, 1994.
38. Gayther, S., Wells, D., SenGupta, S. B., Chapman, P., Neale, K., Tsioupra, K., and Delhanty, J. D. A. Regionally clustered APC mutations are associated with a severe phenotype and occur at a high frequency in new mutation cases of adenomatous polyposis coli. Hum. Mol. Genet., 3: 53-56, 1994.
39. Rubinfeld, B., Albert, I., Porfiri, E., Munemitsu, S., and Polakis, P. Loss of β-catenin regulation by the APC tumor suppressor protein correlates with loss of structure due to common somatic mutations of the gene. Cancer Res., 57: 4624-4630, 1997.
40. Munemitsu, S., Souza, B., Muller, O., Albert, I., Rubinfeld, B., and Polakis, P The APC gene product associates with microtubules in vivo and promotes their assembly in vitro. Cancer Res., 54: 3676-3681, 1994.
41. Smith, K. J., Levy, D. B., Maupin, P., Pollard, T. D., Vogelstein, B., and Kinzler, K. W. Wild-type but not mutant APC associates with the microtubule cytoskeleton. Cancer Res., 54: 3672-3675, 1994.
42. Matsumine, A., Ogai, A., Senda, T., Okumura, N., Satoh, K., Baeg, G-H., Kawahara, T., Kobayashi, S., Okada, M., Toyosnima, K., and Akiyama, T. Binding of APC to the human homologue of the Drosophila discs large tumor suppressor protein. Science (Washington DC), 272: 1020-1023, 1996.
43. Su, L-K., Burrell, M., Hill, D. E., Gyuris, J., Brent, R., Wiltshire, R., Trent, J., Vogelstein, B., and Kinzler, K. W. APC binds to the novel protein EB1. Cancer Res., 55: 2972-2977, 1995.
44. van der Luijt, R. B., Meera Khan, P., Vasen, H. F. A., Breukel, C., Tops, C. M. J., Scott, R. J., and Fodde, R. Germline mutations in the 3′ part of APC exon 15 do not result in truncated proteins and are associated with attenuated adenomatous polyposis coli. Hum. Genet., 98: 727-734, 1996.
45. Friedl, W., Meuschel, S., Caspari, R., Lamberti, C., Krieger, S., Sengteller, M., and Propping, P. Attenuated familial adenomatous polyposis due to a mutation in the 3′ part of the APC gene. A clue for the understanding of the APC gene. Hum. Genet., 97: 579-584, 1996.
46. Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam. Cancer Res., 56: 710-714, 1996.
47. Mahmoud, N. N., Dannenberg, A. J., Mestre, J., Bilinski, R. T., Martucci, C., Newmark, H., Bertagnolli, M. M. Aspirin prevents tumors in a murine model of familial adenomatous polyposis. Surgery (St. Louis), 124: 225-231, 1998.
48. Lynch, H. T., Thorson, A. G., and Smyrk, T. Rectal cancer after prolonged sulindac chemoprevention. Cancer (Phila.), 75: 936-938, 1995.
49. Thorson, A. G., Lynch, H. T., and Smyrk, T. C. Rectal cancer in FAP patient after sulindac. Lancet, 343: 180, 1994.
50. Niv, Y., and Fraser, G. M. Adenocarcinoma in the rectal segment in familial polyposis coli is not prevented by sulindac therapy. Gastroenterology, 107: 854-857, 1994.
51. Pasricha, P. J., Bedi, A., O'Connor, K., Rashid, A., Akhtar, A. J., Zahurak, M. L., Piantadosi, S., Hamilton, S. R., and Giardiello, F. M. The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis. Gastroenterology, 109: 994-998, 1995.
52. Bedi, A., Pasricha, P. J., Akhtar, A. J., Barber, J. P., Bedi, G. C., Giardiello, F. M., Zehnbauer, B. A., Hamilton, S. R., and Jones, R. J. Inhibition of apoptosis during development of colorectal cancer. Cancer Res., 55: 1811-1816, 1995.
53. Piazza, G. A., Rahm, A. L. K., Krutzch, M., Sperl, G., Paranka, N. S., Gross, P. H., Brendel, K., Burt, R. W., Alberts, D. S., Pamukcu, R., and Ahnen, D. J. Antineo-plastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res., 55: 3110-3116, 1995.
54. Shiff, S. J., Qiao, L., Tsai, L., and Rigas, B. Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence and induces apoptosis in HT-29 colon adenocarcinoma cells. J. Clin. Investig., 96: 491-503, 1995.
55. Tsujii, M., and DuBois, R. N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell, 83: 493-501, 1995.